Announcements Trials
Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Breast 10Other 7Plasma cell 6Genitourinary 6Classical hematology 6Thoracic 5Lymphoid 4Head & Neck 3CNS 3Other hematologic neoplasm 2Gastrointestinal 2Dermatologic 2NET 1Myeloid 1Gynecologic 1Endocrine 1

Conditions

Neuroendocrine Tumors 130Gastro-enteropancreatic neuroendocrine tumor 16Pancreatic Neoplasms 14Neoplasms 12Stomach Neoplasms 8Carcinoma, Neuroendocrine 8Carcinoid Tumor 8Prostatic Neoplasms 7Lung Neoplasms 7Carcinoma, Hepatocellular 7Breast Neoplasms 7Thyroid Neoplasms 6Melanoma 6Esophageal Neoplasms 6Colonic Neoplasms 6Rectal Neoplasms 5Pheochromocytoma 5Neoplasm Metastasis 5Gastrointestinal Stromal Tumors 5Carcinoma 5Adenoma, Islet Cell 5Adenocarcinoma 5Testicular Neoplasms 4Skin Neoplasms 4Serotonin Syndrome 4Sarcoma 4Paraganglioma 4Liver Neoplasms 4Kidney Neoplasms 4Head and Neck Neoplasms 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Heart Failure × NET × Clear all
NCT07450287 2026-03-04

CardioNETPOL

National Institute of Cardiology, Warsaw, Poland

Not yet recruiting
120 enrolled
EndocrineNET

Carcinoid Heart Disease, Heart Failure, Heart Valve Diseases, Neuroendocrine Tumors, Serotonin Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡